Australian researchers are hoping to build on promising results for modafinil in debilitating fatigue after stroke with a larger phase III trial. The MIDAS trial, published last year in Stroke, found that modafinil effectively alleviated fatigue and improve quality of life in patients who had experienced a stroke. And according to study author Dr Tom Lillicrap ...
Narcolepsy drug moves to Phase III trial for post-stroke fatigue
13 Sep 2018